JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Practical Algorithm Guiding Seborrheic Dermatitis Treatment in Adults and Adolescents: New Evidence and Consensus Expert Opinion

Published online November 1, 2026

Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease that affects approximately 5% of the global population. 1 I...

read more
Peptides for Hair Growth and Treatment of Hair Loss and Alopecia: A Systematic Review

Published online October 30, 2026

Many patients seek interventions to achieve thicker, fuller hair for aesthetic enhancement. Hair loss is a multifactorial condition im...

read more
Evaluating the Clinical Efficacy, Utility, and Role of the 40-Gene Expression Profiling Test in Assessing Prognosis of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel

Published online October 30, 2026

Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer, and its incidence and prevalence are rising. 1,2 Tr...

read more
A Moisturizer With Centella asiatica and Mandelic Acid Reduces Bruising and Speeds Recovery in Mature Skin

Published online October 30, 2026

Dermatoporosis is a cutaneous syndrome characterized by a progressive loss of skin strength and structural integrity. 1-4 Its clinical...

read more
Implementing Psoriatic Arthritis Screening and Dietary Interventions in Dermatology Practice: A Prospective Clinical Study

Published online October 30, 2026

Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory disease that affects up to 30% of patients with psoriasis (PsO), c...

read more
Tranexamic Acid Mesotherapy for Melasma: An Interventional Study

Published online October 29, 2026

Melasma is a pigmentary disorder affecting over 5 million people in the United States. 1 The term "melasma" is derived from the Greek ...

read more
Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials

Published online October 29, 2026

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with frequent relapses and multisystem involvement, including the jo...

read more
Increased Risk of Skin Cancers in Certain Occupations

Published online October 29, 2026

The incidence of melanoma and non-melanoma skin cancer (NMSC) has been increasing worldwide. 1 NMSC mainly consists of keratinocyte sk...

read more
Immunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy

Published online October 29, 2026

Immunosuppressive and immunomodulatory medications are widely utilized in dermatology to treat chronic inflammatory skin conditions. Ho...

read more
Generative Artificial Intelligence Augmentation of a Clinical Trial of a Dermo-cosmetic Intervention for Acne Remission Maintenance

Published online October 29, 2026

Generative artificial intelligence (AI) is increasingly being adopted in healthcare settings to accelerate innovation. 1 Realistic art...

read more
Impetigo Antibiotic Stewardship and the Need for Treatment Alternatives

Published online October 29, 2026

Increasing rates of antimicrobial resistance in clinical practice underscore the importance of antibiotic stewardship in improving pati...

read more
Biomarkers and Clinical Disease Severity in Hidradenitis Suppurativa: A Linear Mixed-Effects Modeling Study

Published online October 29, 2026

To the Editor, Hidradenitis suppurativa (HS) is a systemic inflammatory disorder with a multifactorial pathophysiology that remains incompletely u...

read more
Central Centrifugal Cicatricial Alopecia and the Use of Xtressé Nutrient Supplement: A Case Series

Published online October 20, 2026

Central Centrifugal Cicatricial Alopecia (CCCA) is characterized by progressive scarring and hair loss in the vertex or crown of the sc...

read more
Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors

Published online October 20, 2026

Psoriatic arthritis (PsA) is a debilitating inflammatory arthropathy and a major long-term complication of psoriasis, affecting up to 3...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD featuring Nordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis

Nordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis

| Atopic Dermatitis, Featured Articles, Latest News | No Comments
Optimizing Atopic Dermatitis Outcomes: Nordic Expert Panel Insights on Emollient Selection and Treatment Concordance Check out this groundbreaking publication featured in the Journal of Drugs in Dermatology. Managing chronic atopic…

Fundamentals of Hyperpigmentation Disorders: Causes, Concerns, and Treatment Strategies, Particularly in Skin of Color Patients

| Dyspigmentation, Featured Articles, Latest News, Skincare | No Comments
Bridging the Evidence Gap in Skin of Color Hyperpigmentation  This is a must-read article from the Journal of Drugs in Dermatology (JDD) that every practicing clinician should have on their…

New Video Abstract: Fundamentals of Hyperpigmentation Disorders: Causes, Concerns, and Treatment Strategies Particularly in Skin of Color Patients with Dr. Susan Taylor!

| Featured Articles, The Latest, Video Abstract | No Comments
Pigmentary disorders, including cutaneous hyperpigmentation, are among the most common dermatologic diagnoses in individuals with SOC, particularly individuals with African, Asian, or Hispanic heritage. The principal hyperpigmentation conditions include melasma, post-inflammatory…
Journal of Drugs in Dermatology JDD featuring SAIGE III: The Role of Environmental Factors in the Development and Severity of Atopic Dermatitis in Young Children

SAIGE III: The Role of Environmental Factors in the Development and Severity of Atopic Dermatitis in Young Children

| Atopic Dermatitis, Featured Articles, Latest News, Pediatrics | No Comments
Protecting the Pediatric Skin Barrier: Expert Consensus on Environmental Triggers and Early Intervention This is a must-read article from JDD for clinicians  managing pediatric skin health. Atopic dermatitis frequently begins in…
Journal of Drugs in Dermatology JDD featuring Beyond the Dark Spot: Modern Strategies for Stubborn Hyperpigmentation

Beyond the Dark Spot: Modern Strategies for Stubborn Hyperpigmentation

| Dyspigmentation, Featured Articles, Latest News, Photoprotection | No Comments
From iron oxides to depigmenting agents, how new research is changing tone correction Unlocking clear skin is a constant goal for patients, which is why hyperpigmentation research routinely tops JDD…

Hot Topics in the JDD: Hidradenitis Suppurativa

| Featured Articles, Hidradenitis Suppurativa, JDD in the Media, Latest News | No Comments
Hidradenitis suppurativa (HS) treatment has drastically changed in the last 15 years with FDA-approved biologics and an understanding of the need for comprehensive care that addresses the multifactorial pathogenesis of…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array of nonsteroidal options, understanding the underpinnings to both use them for their intended purpose, but even more fun, OOOOOOFFFFFF LLLLLLAAAAABBBBEEEELLLL (clearly a fan of off label), is paramount to patient outcomes. Be not overwhelmed I say, as the bench to bedside badass Dr. Christopher Bunick is here for all your on and off label needs. Take a break from the typical Tuesday with a topical translational deep dive into the tantalizing options as host Dr. Adam Friedman tees off with Dr. Bunick for what is certain to be a “tough” (as the kids say) podcast.

Touching on Tailored Topical for Tons of Tough Treatment Tchallenges

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
Tune In

Follow Us